butyrate and glp-1 Sodium reduces high-fat diet-induced non-alcoholic steatohepatitis through upregulation of hepatic GLP-1R expression Amazon.com: GLP-Pro™: Probiotic & Postbiotic

Description

Expert guide inside.

Key Findings: - Increased risk of going over recommended weight gain limits - Higher chances of preterm birth (from 13% to 17%) - Rising cases of gestational diabetes (15% to 20%) - Nearly half faced high blood pressure issues While baby sizes and C-section rates remained similar, the impact on maternal health is significant

#ClinicalTrials #GLP1 #PatientRetention #ClinicalResearch #CRO #MetabolicHealth

Semaglutide shows promise in reducing LDL cholesterol and triglycerides alongside weight loss

Stopping GLP-1 receptor agonists 14 days prior to total hip or knee arthroplasty may reduce several key risk factors associated with anesthesia complications, according to results presented here.“Specifically for semaglutide, stopping that medication 14 days before surgery is safest based upon the dataset that we have to minimize your risks with anesthesia, especially when